Read more about Dr Reddys Laboratories launches Tadalafil Tablets USP in US market on Business Standard. The Cialis brand and generic had U.S. sales of approximately $1.7 billion MAT for the most recent twelve months ending in January 2019 according to IMS Health.
Source: www.business-standard.com
Dr. Reddy’s Laboratories Ltd. has launched Tadalafil Tablets USP in the US market. This tablet is used for the treatment of erectile dysfunction in users. Approved by the U.S. Food and Drug Administration, Tadalafil Tablets are a therapeutic equivalent generic version of Cialis Tablets. Tadalafil Tablets will be available in four strengths including 2.5 mg, 5 mg, 10 mg, and 20 mg, each in a 30-count bottle size.
